Skip to main content
logo
Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
28.68
+1.14 (4.14%)
Apr 17, 2026, 1:25 PM HKT

HKG:1877 Revenue

In the year 2025, Shanghai Junshi Biosciences had annual revenue of 2.50B CNY with 28.23% growth. Shanghai Junshi Biosciences had revenue of 692.54M in the quarter ending December 31, 2025, with 2.28% growth.

Revenue
2.50B CNY
Revenue Growth
+28.23%
P/S Ratio
16.61
Revenue / Employee
860.63K CNY
Employees
2,903
Market Cap
46.18B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.50B550.10M28.23%
Dec 31, 20241.95B445.77M29.67%
Dec 31, 20231.50B49.06M3.38%
Dec 31, 20221.45B-2.57B-63.89%
Dec 31, 20214.02B2.43B152.36%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
3SBio19.69B
Genscript Biotech7.47B
Shanghai Henlius Biotech7.42B
RemeGen3.62B
InnoCare Pharma2.64B
Duality Biotherapeutics2.06B
Biocytogen Pharmaceuticals (Beijing)1.53B
Keymed Biosciences797.12M
Revenue Rankings

Shanghai Junshi Biosciences News

More News